Peak Health Opens Full Staff Marketing
Release time:
2020-07-15
In order to mobilize the enthusiasm of all employees to a greater extent, in early January, the peak season of the Lunar New Year is approaching, Jianfeng Health Technology Company established a "1 1 Direct Purchase Department" to explore a new mode of full-staff marketing. Chen Daiyou, general manager of
Jianfeng Health, said that the establishment of the 1+1 direct purchase department is an attempt of Jianfeng Health to the marketing channel of new media communities. "1" represents every employee of Jianfeng Health and the end consumers of Jianfeng Health respectively. "+" is the establishment of internet plus, new media community marketing and 1+1 direct purchase department, the aim is to actively operate a circle of friends through each employee, try community marketing of new media, and stimulate end consumers to understand, recognize and identify with peak and healthy products, thus generating purchasing behavior, increasing product awareness and brand awareness, and mobilizing the enthusiasm of all employees in marketing. After the establishment of
1+1 Direct Purchase Department, it not only established a service WeChat group, actively promoted all employees to promote friends circle and point-to-point WeChat, and supported door-to-door delivery. The service team also made pictures and texts for product use, so that more non-sales colleagues could understand the products and better promote the products, and cooperated with the Jinhua Daily client to shoot the Spring Festival advertisement micro-video, let more consumers know about peak health products and expand the influence of products. The 1+1 Direct Purchase Department also launched a buy-one-get-two-free discount for Renshou Hall's broken-wall Ganoderma lucidum spore powder for employees inside the peak, which was actively sought after by the employees.
During the prevention and control of the epidemic, although the 1+1 direct purchase department encountered many challenges, such as the outage of express delivery and tight supply, everyone worked together to overcome the difficulties.
1+1 Direct Purchase Department has been established for less than 2 months, mobilizing 80% of peak health's non-sales staff to participate, and more than half of the employees have successfully sold and been rewarded.
It is understood that employees also recognize the full marketing model. Let each employee participate in the marketing of the company, which can better reflect their own value, and at the same time make them feel the sense of achievement and dedication to the company. Sense of belonging. (Yao Lili)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page